ClinicalTrials.gg
Not yet recruitingNCT07677189SENSOR-LBPUpdated Jun 30, 2026

Sensorimotor Balance Training for Chronic Nonspecific Low Back Pain

An interventional study of Sensorimotor Balance Training and Standard Physiotherapy in Chronic Nonspecific Low Back Pain, sponsored by Najran University. Not yet recruiting at 1 site in Saudi Arabia. Open to participants aged 18 Years to 59 Years. Per ClinicalTrials.gov, last updated 2026-06-30.

Sponsored by Najran University · Not applicable, Interventional, and Treatment

How we know

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
80
Allocation
Randomized
Ages
18 Years to 59 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 27 studies in Low Back Pain with a site in Saudi Arabia — 5 open to participants now, 5 under way, none of them phase 3. Low Back Pain · Saudi Arabia.

Planned enrollment
5th of 24
80 · median 60
Started
2026
with 2 others
No phase
24 of 27
5 open now
Registered
26th of 27
by date
Lead sponsor
2 of 27
Najran University

Among the 27 studies in Low Back Pain with a site in Saudi Arabia, this one is the 5th largest by planned enrollment of the 24 interventional ones that give a count, is one of 3 that started in 2026, is one of 24 with no phase, and was the 26th registered.

Low Back Pain

2,930 studies on the registry are indexed under Low Back Pain; 581 are open to participants now.

Browse Low Back Pain studies →

Open to participants now

5 of the 27 studies in Low Back Pain with a site in Saudi Arabia are open now. Recruiting first, the newest first:

All 5 open studies →

A study can be open while its sites in Saudi Arabia have not opened yet or have stopped. Only those recruiting at a site in Saudi Arabia →

Who these studies take

Of the 332 Low Back Pain studies recruiting now, 93 (28%) set no upper age limit and 209 (63%) stop at 75 or younger; 8 take children under 18; 46 take healthy volunteers.

This study: 18 Years to 59 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 27 studies in Low Back Pain with a site in Saudi Arabia, or all of them as a file.
02

Study summary

Chronic nonspecific low back pain is one of the most common causes of pain and disability worldwide. Many people with chronic low back pain experience difficulties with balance, posture, movement control, and daily activities. Sensorimotor balance training is a rehabilitation approach designed to improve balance, body awareness, and neuromuscular control.

The purpose of this randomized controlled trial is to investigate whether sensorimotor balance training is more effective than standard physiotherapy in reducing pain and improving spinal alignment in adults with chronic nonspecific low back pain. Participants will be randomly assigned to either a sensorimotor balance training group or a standard physiotherapy group. Both groups will receive treatment three times per week for 12 weeks.

Pain intensity, functional disability, and spinal alignment will be assessed before and after the intervention. Spinal alignment will be measured using the DIERS Formetric 4D system, a non-invasive and radiation-free technology that evaluates posture and spinal shape. The findings of this study may help identify effective rehabilitation strategies for improving pain, function, and spinal alignment in people with chronic nonspecific low back pain.

Read the detailed description

Chronic nonspecific low back pain (CNSLBP) is a major cause of disability and reduced quality of life worldwide. In addition to pain, individuals with CNSLBP frequently demonstrate impairments in sensorimotor control, proprioception, postural stability, and trunk muscle coordination. These impairments may contribute to persistent symptoms and functional limitations.

Sensorimotor balance training has emerged as a rehabilitation approach aimed at improving sensory integration, neuromuscular control, and dynamic postural stability. Previous studies have reported beneficial effects of sensorimotor-focused interventions on pain and functional outcomes; however, most investigations have relied primarily on self-reported measures, with limited assessment of objective biomechanical changes.

The DIERS Formetric 4D system provides a non-invasive, radiation-free method for evaluating spinal posture and alignment, including measures of trunk imbalance, pelvic tilt, and sagittal spinal curvature. The integration of objective spinal assessment with rehabilitation interventions may provide greater insight into the relationship between symptom improvement and structural-functional adaptations.

This randomized controlled trial aims to evaluate the effects of sensorimotor balance training on pain intensity and spinal alignment in adults with chronic nonspecific low back pain. The study will compare sensorimotor balance training with standard physiotherapy and examine whether improvements in pain are associated with measurable changes in spinal alignment. Findings from this study may contribute to the development of evidence-based rehabilitation strategies for the management of chronic nonspecific low back pain.

03

Conditions studied

  • Chronic Nonspecific Low Back Pain

Browse trials for

Keywords

  • Chronic Nonspecific Low Back Pain
  • Sensorimotor Balance Training
  • Neuromuscular Control
  • Spinal Alignment
  • Physiotherapy
  • Rehabilitation
04

Who can participate

Ages eligible
18 Years to 59 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Adults aged 18 to 59 years. Diagnosis of chronic nonspecific low back pain lasting at least 3 months. Pain intensity score of 4 or greater on the Numeric Pain Rating Scale (NPRS). (BMI) between 25 and 35 kg/m². Ability to safely participate in the exercise program and comply with study procedures.

Exclusion criteria

Exclusion Criteria:

  • Acute low back injury. History of spinal surgery. Neurological disorders affecting movement or balance. Musculoskeletal disorders affecting movement or balance. Professional athletes. Individuals engaged in heavy manual labor. Any medical condition that would prevent safe participation in the intervention program.
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
80 participants (estimated)

Study arms

  • Experimental
    Sensorimotor Balance Training

    Participants in this arm will receive sensorimotor balance training designed to improve proprioception, postural stability, and neuromuscular control. The intervention will be delivered three times per week for 12 weeks. Exercises include wobble board balance training, core activation exercises, and dynamic single-leg stance activities, with progressive increases in difficulty throughout the intervention period.

    Behavioral: Sensorimotor Balance Training

  • Active comparator
    Standard Physiotherapy

    Participants in this arm will receive standard physiotherapy treatment consisting of stretching and core strengthening exercises. Treatment will be provided three times per week for 12 weeks using a standardized progression protocol.

    Behavioral: Standard Physiotherapy

Interventions

  • BehavioralSensorimotor Balance Training

    Participants will receive a structured sensorimotor balance training program designed to improve proprioception, postural stability, and neuromuscular control. The intervention will be delivered three times per week for 12 weeks, with each session lasting approximately 45 minutes. Exercises include wobble board balance training, core activation exercises, and dynamic single-leg stance activities. Exercise difficulty will be progressively increased every two weeks according to participant performance and

  • BehavioralStandard Physiotherapy

    Participants will receive standard physiotherapy treatment consisting of stretching and core strengthening exercises. The intervention will be delivered three times per week for 12 weeks, with each session lasting approximately 45 minutes. A standardized progression protocol will be followed throughout the intervention period to ensure consistency of treatment delivery across participants.

06

What researchers measure

Primary outcomes

  1. Pain Intensity Measured by the Numeric Pain Rating Scale (NPRS)

    The Numeric Pain Rating Scale (NPRS) is a self-reported measure of pain intensity scored from 0 to 10, where 0 indicates no pain and 10 indicates the worst imaginable pain. The primary outcome will be the change in pain intensity from baseline to the end of the 12-week intervention period.

    Time frame: Baseline and Week 12

  2. Spinal Alignment Measured by DIERS Formetric 4D

    Spinal alignment will be assessed using the DIERS Formetric 4D system, a non-invasive and radiation-free surface topography method. Parameters evaluated will include trunk imbalance, pelvic tilt, and sagittal spinal curvature. The outcome measure will be the change in spinal alignment parameters from baseline to the end of the intervention period.

    Time frame: Baseline and Week 12

Secondary outcomes

  1. Functional Disability Measured by the Oswestry Disability Index (ODI)

    Functional disability will be assessed using the Oswestry Disability Index (ODI), a validated questionnaire measuring the impact of low back pain on daily activities and functional performance. The outcome measure will be the change in ODI score from baseline to the end of the 12-week intervention period.

    Time frame: Baseline and Week 12

07

Study locations

1 site
  • Physiotherapy Clinics, Department of Medical Rehabilitation Sciences, College of Applied Medical Sciences, Najran University
    Najran, Najran Region 61441, Saudi Arabia
    • Husam Yahya Alfaifi, PhD · ContactHyalfifi@nu.edu.sa · +966560366600
    • Husam Yahya Alfaifi, PhD · Sub investigator
    • Mohammad Abdel Jarrar, Msc · Sub investigator
    • Saeed Yahya Al Adal, PhD · Sub investigator
08

References and documents

Individual participant data

Plan to share: Undecided — A decision regarding the sharing of de-identified individual participant data (IPD) has not yet been made. The study consent form includes an option for participants to allow future use of their de-identified data for research purposes. Any future data-sharing arrangements will be considered after study completion in accordance with participant consent, ethical approvals, and institutional policies.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for Jul 2026; primary completion for Jan 2027, 6 months later.

Of 1,234 non-industry interventional studies with no phase under Low Back Pain, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 26. This study's planned 6 months is below that.

Counting every sponsor, half of 1,290 studies reached it within 11 months; a quarter within 5 and three quarters within 27.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 24, 2026
First posted
Jun 30, 2026
StartEst.
Jul 1, 2026
Primary completionEst.
Jan 1, 2027
CompletionEst.
Mar 1, 2027
Last update
Jun 30, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 30, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07677189
Lead sponsor
Najran University
Responsible party
Adel Alshahrani (Associate Professor, Department of Medical Rehabilitation Sciences, Najran University, Najran University) — Principal investigator
First posted
Jun 30, 2026
Start date
Jul 1, 2026 (estimated)
Primary completion
Jan 1, 2027 (estimated)
Completion
Mar 1, 2027 (estimated)
Last update
Jun 30, 2026

Study contacts

Adel Alshahrani, PhD, PT
Contact
amsalshahrani@nu.edu.sa
+966 54 822 6011

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jun 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion